{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:22:32Z","timestamp":1792466552076,"version":"4.5.0"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T00:00:00Z","timestamp":1677974400000},"content-version":"am","delay-in-days":277,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE029637"],"award-info":[{"award-number":["R01DE029637"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["\/ NIDCR K08DE025337"],"award-info":[{"award-number":["\/ NIDCR K08DE025337"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG067510"],"award-info":[{"award-number":["R01AG067510"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM130457"],"award-info":[{"award-number":["P20GM130457"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM121342"],"award-info":[{"award-number":["P20GM121342"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["\/ NIDDK P30DK123704"],"award-info":[{"award-number":["\/ NIDDK P30DK123704"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010874","name":"American Society for Bone and Mineral Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bone.2022.116377","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T02:50:55Z","timestamp":1646275855000},"page":"116377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"special_numbering":"C","title":["Tetracyclines and bone: Unclear actions with potentially lasting effects"],"prefix":"10.1016","volume":"159","author":[{"given":"Amy J.","family":"Warner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica D.","family":"Hathaway-Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Lubker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad M.","family":"Novince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2022.116377_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2011.06354.x","article-title":"The history of the tetracyclines","volume":"1241","author":"Nelson","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2022.116377_bb0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025387","article-title":"Tetracycline antibiotics and resistance","volume":"6","author":"Grossman","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bone.2022.116377_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/11530200-000000000-00000","article-title":"The role of tetracyclines in rosacea","volume":"11","author":"Alikhan","year":"2010","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40257-020-00560-w","article-title":"Oral antibiotics for acne","volume":"22","author":"Patel","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13122085","article-title":"The development of third-generation tetracycline antibiotics and new perspectives","volume":"13","author":"Rusu","year":"2021","journal-title":"Pharmaceutics"},{"issue":"82","key":"10.1016\/j.bone.2022.116377_bb0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/prd.12315","article-title":"Periodontal therapeutics: current host-modulation agents and future directions","volume":"2000","author":"Golub","year":"2020","journal-title":"Periodontology"},{"key":"10.1016\/j.bone.2022.116377_bb0035","article-title":"Studies on the distribution of tritium-labelled dihydrostreptomycin and tetracycline in the body","volume":"1\u201389","author":"Andre","year":"1956","journal-title":"Acta Radiol. Suppl."},{"key":"10.1016\/j.bone.2022.116377_bb0040","first-page":"87","article-title":"Bone localization of the tetracyclines","volume":"19","author":"Milch","year":"1957","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bone.2022.116377_bb0045","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2106\/00004623-195840040-00013","article-title":"Fluorescence of tetracycline antibiotics in bone","volume":"40-a","author":"Milch","year":"1958","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2022.116377_bb0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0022-3565(25)25877-3","article-title":"Concentration and persistence of tetracycline and chlortetracycline in bone","volume":"130","author":"Buyske","year":"1960","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bone.2022.116377_bb0055","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/00220345650440031001","article-title":"Tetracycline binding by skeletal tissue","volume":"44","author":"Myers","year":"1965","journal-title":"J. Dent. Res."},{"issue":"Suppl 10","key":"10.1016\/j.bone.2022.116377_bb0060","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/184728b0","article-title":"Inhibition of skeletal formation in the chick embryo following administration of tetracycline","volume":"184","author":"Bevelander","year":"1959","journal-title":"Nature"},{"key":"10.1016\/j.bone.2022.116377_bb0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0012-1606(60)90011-7","article-title":"The effect of tetracycline on the development of the skeletal system of the chick embryo","volume":"2","author":"Bevelander","year":"1960","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bone.2022.116377_bb0070","first-page":"365","article-title":"The effect on the rat fetus of transplacentally acquired tetracycline","volume":"4","author":"Bevelander","year":"1962","journal-title":"Biologia neonatorum. Neo-natal studies"},{"key":"10.1016\/j.bone.2022.116377_bb0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archpedi.1963.02080040455005","article-title":"Growth inhibition of prematures receiving tetracycline: a clinical and laboratory investigation of tetracycline-induced bone fluorescence","volume":"105","author":"Cohlan","year":"1963","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.bone.2022.116377_bb0080","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S8756-3282(96)00302-X","article-title":"Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats","volume":"19","author":"Williams","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116377_bb0085","first-page":"668","article-title":"Controlled study of the effect of prenatal tetracycline on primary dentition","volume":"5","author":"Porter","year":"1965","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bone.2022.116377_bb0090","first-page":"75","article-title":"Effect of administration of tetracycline in pregnancy on the primary dentition of the offspring","volume":"25","author":"Genot","year":"1970","journal-title":"J. Oral. Med."},{"key":"10.1016\/j.bone.2022.116377_bb0095","first-page":"599","article-title":"Effects of low doses of hydrochloride tetracycline on bone metabolism and uterus in ovariectomized rats","volume":"24","author":"Li","year":"2003","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bone.2022.116377_bb0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00223-004-0097-x","article-title":"Effects of doxycycline on mechanical properties of bones in rats with ovariectomy-induced osteopenia","volume":"75","author":"Pytlik","year":"2004","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2022.116377_bb0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01149961","article-title":"Tetracyclines modulate cytosolic Ca2+ responses in the osteoclast associated with \"Ca2+ receptor\" activation","volume":"13","author":"Bax","year":"1993","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bone.2022.116377_bb0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF01149962","article-title":"The effect of tetracyclines on quantitative measures of osteoclast morphology","volume":"13","author":"Zaidi","year":"1993","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bone.2022.116377_bb0115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bone.2004.02.028","article-title":"Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors","volume":"35","author":"Holmes","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116377_bb0120","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.archoralbio.2011.02.002","article-title":"Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells","volume":"56","author":"Nagasawa","year":"2011","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.bone.2022.116377_bb0125","article-title":"Tetracycline analogs inhibit osteoclast differentiation by suppressing MMP-9-mediated histone H3 cleavage","volume":"20","author":"Kim","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2022.116377_bb0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/AAC.00729-05","article-title":"Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines","volume":"51","author":"Duewelhenke","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bone.2022.116377_bb0135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.archoralbio.2006.10.005","article-title":"Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells","volume":"52","author":"Gomes","year":"2007","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.bone.2022.116377_bb0140","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jss.2012.03.072","article-title":"Low dose of doxycyline promotes early differentiation of preosteoblasts by partially regulating the expression of estrogen receptors","volume":"178","author":"Park","year":"2012","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bone.2022.116377_bb0145","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/jor.21343","article-title":"Effect of various concentrations of antibiotics on osteogenic cell viability and activity","volume":"29","author":"Rathbone","year":"2011","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2022.116377_bb0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1749-6632.1948.tb27262.x","article-title":"Aureomycin; a product of the continuing search for new antibiotics","volume":"51","author":"Duggar","year":"1948","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2022.116377_bb0155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1515\/hsz-2013-0292","article-title":"Tetracycline antibiotics and resistance mechanisms","volume":"395","author":"Nguyen","year":"2014","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bone.2022.116377_bb0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcp.2016.10.001","article-title":"History of antimicrobial drug discovery: major classes and health impact","volume":"133","author":"Aminov","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bone.2022.116377_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6976.1996.tb00251.x","article-title":"Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution","volume":"19","author":"Roberts","year":"1996","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bone.2022.116377_bb0170","first-page":"371","article-title":"Antibacterial activity in mice of minocycline, a new tetracycline","volume":"6","author":"Redin","year":"1966","journal-title":"Antimicrob. Agents Chemother. (Bethesda)"},{"key":"10.1016\/j.bone.2022.116377_bb0175","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1021\/ja00900a027","article-title":"6-deoxytetracyclines. IV.1,2 preparation, C-6 stereochemistry, and reactions","volume":"85","author":"Stephens","year":"1963","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bone.2022.116377_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01652176.1993.9694358","article-title":"Pharmacokinetics and bioavailability of doxycycline hyclate after oral administration in calves","volume":"15","author":"Meijer","year":"1993","journal-title":"Vet Q"},{"key":"10.1016\/j.bone.2022.116377_bb0185","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0960-894X(99)00216-4","article-title":"Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936","volume":"9","author":"Sum","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bone.2022.116377_bb0190","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jac\/dki291","article-title":"Tigecycline: what is it, and where should it be used?","volume":"56","author":"Livermore","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bone.2022.116377_bb0195","doi-asserted-by":"crossref","first-page":"i11","DOI":"10.1093\/jac\/dkn242","article-title":"Tigecycline pharmacokinetic\/pharmacodynamic update","volume":"62","author":"MacGowan","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bone.2022.116377_bb0200","doi-asserted-by":"crossref","first-page":"7044","DOI":"10.1128\/AAC.01536-15","article-title":"Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline","volume":"59","author":"Honeyman","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bone.2022.116377_bb0205","doi-asserted-by":"crossref","DOI":"10.15190\/d.2019.15","article-title":"FDA approved antibacterial drugs: 2018-2019","volume":"7","author":"Andrei","year":"2019","journal-title":"Discoveries (Craiova)"},{"key":"10.1016\/j.bone.2022.116377_bb0210","doi-asserted-by":"crossref","first-page":"20530","DOI":"10.1073\/pnas.2008671117","article-title":"Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome","volume":"117","author":"Batool","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2022.116377_bb0215","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00128071-200304050-00002","article-title":"Antibacterial therapy for acne: a guide to selection and use of systemic agents","volume":"4","author":"Tan","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"issue":"Suppl 3","key":"10.1016\/j.bone.2022.116377_bb0220","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1542\/peds.2013-0490B","article-title":"Evidence-based recommendations for the diagnosis and treatment of pediatric acne","volume":"131","author":"Eichenfield","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.bone.2022.116377_bb0225","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijantimicag.2013.01.020","article-title":"All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials","volume":"41","author":"McGovern","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bone.2022.116377_bb0230","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2014.05.012","article-title":"Mining the human gut microbiota for effector strains that shape the immune system","volume":"40","author":"Ahern","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bone.2022.116377_bb0235","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.237","article-title":"Succession of the Turkey gastrointestinal bacterial microbiome related to weight gain","volume":"1","author":"Danzeisen","year":"2013","journal-title":"PeerJ"},{"key":"10.1016\/j.bone.2022.116377_bb0240","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01174-18","article-title":"Randomized, double-blind, placebo-controlled studies of the safety and pharmacokinetics of single and multiple ascending doses of eravacycline","volume":"62","author":"Newman","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bone.2022.116377_bb0245","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.imbio.2008.09.005","article-title":"Intestinal bifidobacterium association in germ-free T cell receptor transgenic mice down-regulates dietary antigen-specific immune responses of the small intestine but enhances those of the large intestine","volume":"214","author":"Tsuda","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.bone.2022.116377_bb0250","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01297-18","article-title":"Microbiological profile of sarecycline, a novel targeted Spectrum tetracycline for the treatment of acne vulgaris","volume":"63","author":"Zhanel","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bone.2022.116377_bb0255","series-title":"StatPearls","author":"Shutter","year":"2020"},{"key":"10.1016\/j.bone.2022.116377_bb0260","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bone.2022.116377_bb0265","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0270","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.bone.2022.116377_bb0275","doi-asserted-by":"crossref","first-page":"966","DOI":"10.2165\/00003495-199651060-00005","article-title":"Practical guidelines for the treatment of cholera","volume":"51","author":"Seas","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.bone.2022.116377_bb0280","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"ACG clinical guideline: treatment of helicobacter pylori infection","volume":"112","author":"Chey","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bone.2022.116377_bb0285","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.adaj.2015.01.026","article-title":"Evidence-based clinical practice guideline on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts","volume":"146","author":"Smiley","year":"2015","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.bone.2022.116377_bb0290","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00003495-197509040-00005","article-title":"Minocycline: a review of its antibacterial and pharmacokinetic properties and therapeutic use","volume":"9","author":"Brogden","year":"1975","journal-title":"Drugs"},{"key":"10.1016\/j.bone.2022.116377_bb0295","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/mdr.2016.0043","article-title":"Minocycline and tigecycline: what is their role in the treatment of carbapenem-resistant gram-negative organisms?","volume":"23","author":"Shankar","year":"2017","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.bone.2022.116377_bb0300","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1128\/AAC.49.4.1622-1625.2005","article-title":"Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria","volume":"49","author":"Newton","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bone.2022.116377_bb0305","doi-asserted-by":"crossref","DOI":"10.3201\/eid2002.130687","article-title":"Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults","volume":"20","author":"Hendricks","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.bone.2022.116377_bb0310","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4269\/ajtmh.19-0648","article-title":"Impact of doxycycline as malaria prophylaxis on risk of influenza-like illness among international travelers","volume":"102","author":"Lago","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bone.2022.116377_bb0315","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.diagmicrobio.2005.05.006","article-title":"Pharmacokinetic\/pharmacodynamic profile for tigecycline-a new glycylcycline antimicrobial agent","volume":"52","author":"Meagher","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"Suppl 5","key":"10.1016\/j.bone.2022.116377_bb0320","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/431675","article-title":"The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam","volume":"41","author":"Ellis-Grosse","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl 5","key":"10.1016\/j.bone.2022.116377_bb0325","doi-asserted-by":"crossref","first-page":"S354","DOI":"10.1086\/431676","article-title":"The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data","volume":"41","author":"Babinchak","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bone.2022.116377_bb0330","unstructured":"N. C. F. B. Information < https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Sarecycline.> (n.d.)."},{"key":"10.1016\/j.bone.2022.116377_bb0335","author":"UpToDate","year":"2022"},{"key":"10.1016\/j.bone.2022.116377_bb0340","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJMcp033487","article-title":"Clinical practice","volume":"352","author":"James","year":"2005","journal-title":"Acne. N Engl J Med"},{"key":"10.1016\/j.bone.2022.116377_bb0345","first-page":"9","article-title":"Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance","volume":"79","author":"Leyden","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.bone.2022.116377_bb0350","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","article-title":"The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology","volume":"55","author":"Bickers","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0355","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.12149","article-title":"Epidemiology of acne vulgaris","volume":"168","author":"Bhate","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0360","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaad.2014.02.031","article-title":"A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: investigating practice gaps and potential cost-savings","volume":"71","author":"Lee","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0365","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2015.09.046","article-title":"The use of oral antibiotics before isotretinoin therapy in patients with acne","volume":"74","author":"Nagler","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0370","first-page":"18","volume":"9","author":"Del Rosso","year":"2016","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0375","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2165\/00003495-200464210-00002","article-title":"Topical antibacterial therapy for acne vulgaris","volume":"64","author":"Dreno","year":"2004","journal-title":"Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.bone.2022.116377_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1525-1470.2008.00667.x","article-title":"Practical considerations in acne treatment and the clinical impact of topical combination therapy","volume":"25","author":"Krakowski","year":"2008","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0385","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/archderm.1984.01650460048018","article-title":"Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy","volume":"120","author":"Esterly","year":"1984","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0390","first-page":"987","article-title":"Once-daily Oral sarecycline 1.5 mg\/kg\/day is effective for moderate to severe acne vulgaris: results from two identically designed, phase 3, randomized, double-blind clinical trials","volume":"17","author":"Moore","year":"2018","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0395","first-page":"E53","article-title":"Safety and tolerability of sarecycline for the treatment of acne vulgaris: results from a phase III, multicenter, open-label study and a phase I phototoxicity study","volume":"12","author":"Pariser","year":"2019","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0400","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40265-019-1053-4","article-title":"Sarecycline: first global approval","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.bone.2022.116377_bb0405","first-page":"1","article-title":"An overview of sarecycline for the treatment of moderate-to-severe acne vulgaris","author":"Valente Duarte de Sousa","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bone.2022.116377_bb0410","first-page":"6","article-title":"Antibiotic resistance in the topical treatment of acne vulgaris","volume":"73","author":"Leyden","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.bone.2022.116377_bb0415","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne: a report from a global Alliance to improve outcomes in acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0420","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(04)17591-0","article-title":"Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial","volume":"364","author":"Ozolins","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2022.116377_bb0425","author":"Graber","year":"2021"},{"key":"10.1016\/j.bone.2022.116377_bb0430","series-title":"Clinical and Research Information on Drug-Induced Liver Injury","author":"LiverTox","year":"2022"},{"key":"10.1016\/j.bone.2022.116377_bb0435","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1529-8019.2012.01497.x","article-title":"New antibiotic therapies for acne and rosacea","volume":"25","author":"Mays","year":"2012","journal-title":"Dermatol. Ther."},{"issue":"664-668","key":"10.1016\/j.bone.2022.116377_bb0440","first-page":"670","article-title":"The role of Periostat in the management of adult periodontitis: a critical assessment","volume":"20","author":"Greenstein","year":"1999","journal-title":"Compend Contin Educ Dent"},{"key":"10.1016\/j.bone.2022.116377_bb0445","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1600-051X.2004.00558.x","article-title":"Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review","volume":"31","author":"Preshaw","year":"2004","journal-title":"Journal of clinical periodontology"},{"key":"10.1016\/j.bone.2022.116377_bb0450","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.phrs.2010.12.003","article-title":"Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD)","volume":"63","author":"Caton","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bone.2022.116377_bb0455","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMcp1506630","article-title":"Rosacea","volume":"377","author":"van Zuuren","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2022.116377_bb0460","first-page":"19","article-title":"Subantimicrobial dose doxycycline: a unique treatment for rosacea","volume":"75","author":"Berman","year":"2005","journal-title":"Cutis"},{"key":"10.1016\/j.bone.2022.116377_bb0465","first-page":"113","article-title":"Recently approved systemic therapies for acne vulgaris and rosacea","volume":"80","author":"Del Rosso","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.bone.2022.116377_bb0470","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.jaad.2013.04.041","article-title":"Emerging therapies in rosacea","volume":"69","author":"Layton","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0475","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3565(25)25876-1","article-title":"Metabolism of tetracycline in the rat and the dog","volume":"130","author":"Kelly","year":"1960","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bone.2022.116377_bb0480","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/10520296009114729","article-title":"Tetracycline staining of newly forming bone and mineralizing cartilage in vivo","volume":"35","author":"Frost","year":"1960","journal-title":"Stain. Technol."},{"key":"10.1016\/j.bone.2022.116377_bb0485","first-page":"87","article-title":"Human osteoblastic activity. II. Measurement of the biological half-life of bones with the aid of tetracyclines","volume":"9","author":"Frost","year":"1961","journal-title":"Henry Ford Hosp. Med. Bull."},{"key":"10.1016\/j.bone.2022.116377_bb0490","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1139\/y63-146","article-title":"Mean formation time of human osteons","volume":"41","author":"Frost","year":"1963","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.bone.2022.116377_bb0495","first-page":"312","article-title":"Experimental multiband tetracycline measurement of lamellar osteoblastic activity","volume":"9","author":"Frost","year":"1961","journal-title":"Henry Ford Hosp. Med. Bull."},{"key":"10.1016\/j.bone.2022.116377_bb0500","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1139\/y63-005","article-title":"Measurement of human bone formation by means of tetracycline labelling","volume":"41","author":"Frost","year":"1963","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.bone.2022.116377_bb0505","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"Journal of bone and mineral research\u202f: the official journal of the American Society for Bone and Mineral Research"},{"key":"10.1016\/j.bone.2022.116377_bb0510","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116377_bb0515","series-title":"Basic and Applied Bone Biology","first-page":"131","author":"Matthew","year":"2014"},{"key":"10.1016\/j.bone.2022.116377_bb0520","first-page":"457","article-title":"Minocycline hyperpigmentation: skin, tooth, nail, and bone involvement","volume":"33","author":"Wolfe","year":"1984","journal-title":"Cutis"},{"key":"10.1016\/j.bone.2022.116377_bb0525","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0030-4220(84)90056-2","article-title":"An unusual case of oral pigmentation","volume":"58","author":"Fendrich","year":"1984","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"10.1016\/j.bone.2022.116377_bb0530","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.fas.2011.01.011","article-title":"Black bone disease of the foot. Minocycline related pigmentation","volume":"17","author":"Middleton","year":"2011","journal-title":"Foot Ankle Surg."},{"key":"10.1016\/j.bone.2022.116377_bb0535","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.3928\/01477447-20120426-30","article-title":"Minocycline-induced black bone disease encountered during total knee arthroplasty","volume":"35","author":"Reed","year":"2012","journal-title":"Orthopedics"},{"key":"10.1016\/j.bone.2022.116377_bb0540","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.jfas.2012.10.018","article-title":"Black bone disease of the foot: a case study and review of literature demonstrating a correlation of long-term minocycline therapy and bone hyperpigmentation","volume":"52","author":"Kerbleski","year":"2013","journal-title":"J. Foot Ankle Surg."},{"key":"10.1016\/j.bone.2022.116377_bb0545","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1079-2104(05)80128-3","article-title":"Oral presentation of minocycline-induced black bone disease","volume":"79","author":"Odell","year":"1995","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.bone.2022.116377_bb0550","first-page":"154","article-title":"Minocycline induced pigmentation of the oral cavity","volume":"40","author":"Salman","year":"1985","journal-title":"J. Oral Med."},{"key":"10.1016\/j.bone.2022.116377_bb0555","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1902\/jop.1988.59.2.112","article-title":"Pigmentation of the jawbones and teeth secondary to minocycline hydrochloride therapy","volume":"59","author":"Cale","year":"1988","journal-title":"J. Periodontol."},{"key":"10.1016\/j.bone.2022.116377_bb0560","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1902\/jop.1997.68.1.84","article-title":"Minocycline-induced intraoral pharmacogenic pigmentation: case reports and review of the literature","volume":"68","author":"Westbury","year":"1997","journal-title":"J. Periodontol."},{"key":"10.1016\/j.bone.2022.116377_bb0565","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1902\/jop.2003.74.5.669","article-title":"Minocycline-induced staining of torus palatinus and alveolar bone","volume":"74","author":"Ayangco","year":"2003","journal-title":"J. Periodontol."},{"key":"10.1016\/j.bone.2022.116377_bb0570","first-page":"554","article-title":"Blue palate and alveolar ridge","volume":"52","author":"Damm","year":"2004","journal-title":"General dentistry"},{"key":"10.1016\/j.bone.2022.116377_bb0575","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.tripleo.2003.11.006","article-title":"Oral mucosal pigmentation secondary to minocycline therapy: report of two cases and a review of the literature","volume":"97","author":"Treister","year":"2004","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.bone.2022.116377_bb0580","first-page":"939","article-title":"Black bones following long-term minocycline treatment","volume":"115","author":"Rumbak","year":"1991","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.bone.2022.116377_bb0585","first-page":"146","article-title":"Minocycline-induced blue-green discoloration of bone. A case report","volume":"86","author":"McCleskey","year":"2004","journal-title":"The journal of bone and joint surgeryAmerican"},{"key":"10.1016\/j.bone.2022.116377_bb0590","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1479-666X(04)80008-8","article-title":"Black pigmentation of bone due to long-term minocycline use","volume":"2","author":"Pandit","year":"2004","journal-title":"Surgeon"},{"key":"10.1016\/j.bone.2022.116377_bb0595","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3928\/0147-7447-20050501-20","article-title":"Minocycline-induced black bone disease","volume":"28","author":"Hepburn","year":"2005","journal-title":"Orthopedics"},{"key":"10.1016\/j.bone.2022.116377_bb0600","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1177\/1753193410378953","article-title":"Metacarpal darkening associated with minocycline therapy","volume":"35","author":"Somayazula","year":"2010","journal-title":"J. Hand Surg. Eur. Vol."},{"key":"10.1016\/j.bone.2022.116377_bb0605","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4055\/cios.2012.4.3.181","article-title":"Minocycline-induced periarticular black bones in inflamed joints which underwent arthroplastic reconstruction","volume":"4","author":"Yang","year":"2012","journal-title":"Clin. Orthop. Surg."},{"key":"10.1016\/j.bone.2022.116377_bb0610","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0041-008X(67)90036-1","article-title":"Metabolism and tissue distribution of radioisotopically labelled minocycline","volume":"11","author":"Kelly","year":"1967","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bone.2022.116377_bb0615","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1476-5381.1965.tb02052.x","article-title":"A comparative study of the actions of six tetracyclines on the development of the chick embryo","volume":"25","author":"Hughes","year":"1965","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.bone.2022.116377_bb0620","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/00220345660450013601","article-title":"The effects of tetracyclines on teeth and bones","volume":"45","author":"Johnson","year":"1966","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2022.116377_bb0625","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1471-0528.1954.tb07720.x","article-title":"Placental transmission of antibiotics","volume":"61","author":"Charles","year":"1954","journal-title":"J. Obstet. Gynaecol. Br. Emp."},{"key":"10.1016\/j.bone.2022.116377_bb0630","first-page":"618","article-title":"Transplacental transmission of demethylchlortetracycline and toxicity studies in premature and full term, newly born infants","volume":"7","author":"Gibbons","year":"1960","journal-title":"Antibiotic Med. Clin. Ther."},{"key":"10.1016\/j.bone.2022.116377_bb0635","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/dth.12077","article-title":"Treatment of acne vulgaris in pregnant patients","volume":"26","author":"Pugashetti","year":"2013","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.bone.2022.116377_bb0640","first-page":"190","article-title":"The tetracyclines: a review of the LITERATURE\u20131948 through 1963","volume":"1","author":"Johnson","year":"1964","journal-title":"J. Oral Ther. Pharmacol."},{"key":"10.1016\/j.bone.2022.116377_bb0645","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bone.2022.116377_bb0650","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2165\/00128072-200204120-00006","article-title":"Antibiotics and breast-feeding: a critical review of the literature","volume":"4","author":"Chung","year":"2002","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.bone.2022.116377_bb0655","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(62)91840-8","article-title":"Teeth pigmented by tetracycline","volume":"1","author":"Wallman","year":"1962","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2022.116377_bb0660","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/154405910508400703","article-title":"Drug-induced disorders of teeth","volume":"84","author":"Tredwin","year":"2005","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2022.116377_bb0665","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-4632.2004.02108.x","article-title":"Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity","volume":"43","author":"S\u00e1nchez","year":"2004","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.bone.2022.116377_bb0670","doi-asserted-by":"crossref","first-page":"15316","DOI":"10.1038\/s41598-019-51702-y","article-title":"Doxycycline reduces osteopenia in female rats","volume":"9","author":"de Figueiredo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2022.116377_bb0675","first-page":"27","article-title":"Tetracycline administration prevents diabetes-induced osteopenia in the rat: initial observations","volume":"68","author":"Golub","year":"1990","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.bone.2022.116377_bb0680","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bonr.2014.10.001","article-title":"Effects of long-term doxycycline on bone quality and strength in diabetic male DBA\/2J mice","volume":"1","author":"Fowlkes","year":"2015","journal-title":"Bone Rep."},{"key":"10.1016\/j.bone.2022.116377_bb0685","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S8756-3282(97)00104-X","article-title":"Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats","volume":"21","author":"Bain","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116377_bb0690","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ar.1092310105","article-title":"Tetracycline administration restores osteoblast structure and function during experimental diabetes","volume":"231","author":"Sasaki","year":"1991","journal-title":"Anat. Rec."},{"key":"10.1016\/j.bone.2022.116377_bb0695","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF00296771","article-title":"Tetracycline administration increases collagen synthesis in osteoblasts of streptozotocin-induced diabetic rats: a quantitative autoradiographic study","volume":"50","author":"Sasaki","year":"1992","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2022.116377_bb0700","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ar.1092270406","article-title":"Tetracycline administration normalizes the structure and acid phosphatase activity of osteoclasts in streptozotocin-induced diabetic rats","volume":"227","author":"Kaneko","year":"1990","journal-title":"Anat. Rec."},{"key":"10.1016\/j.bone.2022.116377_bb0705","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jbmr.5650071111","article-title":"Regulation of cytoplasmic calcium concentration in tetracycline-treated osteoclasts","volume":"7","author":"Donahue","year":"1992","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116377_bb0710","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/BF01946671","article-title":"Tetracyclines inhibit parathyroid hormone-induced bone resorption in organ culture","volume":"40","author":"Gomes","year":"1984","journal-title":"Experientia"},{"key":"10.1016\/j.bone.2022.116377_bb0715","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00223-009-9328-5","article-title":"Tetracyclines inhibit rat osteoclast formation and activity in vitro and affect bone turnover in young rats in vivo","volume":"86","author":"Zhou","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2022.116377_bb0720","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF01976761","article-title":"Effect of tetracyclines which have metalloproteinase inhibitory capacity on basal and heparin-stimulated bone resorption by chick osteoclasts","volume":"40","author":"Chowdhury","year":"1993","journal-title":"Agents Actions"},{"key":"10.1016\/j.bone.2022.116377_bb0725","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S8756-3282(00)00297-0","article-title":"Tetracyclines induce apoptosis in osteoclasts","volume":"27","author":"Bettany","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116377_bb0730","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.yexcr.2011.03.014","article-title":"Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo","volume":"317","author":"Franco","year":"2011","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bone.2022.116377_bb0735","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jcb.240550303","article-title":"Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone","volume":"55","author":"Parfitt","year":"1994","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bone.2022.116377_bb0740","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/bonekey.2013.215","article-title":"Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit","volume":"3","author":"Sims","year":"2014","journal-title":"BoneKEy reports"},{"key":"10.1016\/j.bone.2022.116377_bb0745","first-page":"115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2022.116377_bb0750","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2017.1769","article-title":"Association between linear growth and bone accrual in a diverse cohort of children and adolescents","volume":"171","author":"McCormack","year":"2017","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.bone.2022.116377_bb0755","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00198-015-3440-3","article-title":"The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations","volume":"27","author":"Weaver","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2022.116377_bb0760","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.412","article-title":"Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass","volume":"26","author":"Baxter-Jones","year":"2011","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116377_bb0765","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/jcem-73-3-555","article-title":"Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence","volume":"73","author":"Bonjour","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2022.116377_bb0770","series-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","first-page":"38","author":"Bonewald","year":"2018"},{"key":"10.1016\/j.bone.2022.116377_bb0775","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/421746","article-title":"Biology of bone tissue: structure, function, and factors that influence bone cells","volume":"2015","author":"Florencio-Silva","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bone.2022.116377_bb0780","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00003088-198815060-00001","article-title":"Clinical pharmacokinetics of doxycycline and minocycline","volume":"15","author":"Saivin","year":"1988","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bone.2022.116377_bb0785","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0090-9556(25)07851-1","article-title":"Metabolism of minocycline in humans","volume":"10","author":"Nelis","year":"1982","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bone.2022.116377_bb0790","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0378-4347(91)80174-B","article-title":"Identification and determination of the two principal metabolites of minocycline in humans","volume":"568","author":"B\u00f6cker","year":"1991","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.bone.2022.116377_bb0795","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/jbmr.1588","article-title":"The gut microbiota regulates bone mass in mice","volume":"27","author":"Sjogren","year":"2012","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116377_bb0800","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.aad8588","article-title":"Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition","volume":"351","author":"Schwarzer","year":"2016","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bone.2022.116377_bb0805","doi-asserted-by":"crossref","first-page":"E7554","DOI":"10.1073\/pnas.1607235113","article-title":"Gut microbiota induce IGF-1 and promote bone formation and growth","volume":"113","author":"Yan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2022.116377_bb0810","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1038\/s41598-017-06126-x","article-title":"Commensal gut microbiota immunomodulatory actions in bone marrow and liver have catabolic effects on skeletal homeostasis in health","volume":"7","author":"Novince","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2022.116377_bb0815","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1172\/JCI86062","article-title":"Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics","volume":"126","author":"Li","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2022.116377_bb0820","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ajpath.2018.10.017","article-title":"Antibiotic perturbation of gut microbiota dysregulates osteoimmune cross talk in postpubertal skeletal development","volume":"189","author":"Hathaway-Schrader","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2022.116377_bb0825","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/1471-2334-13-267","article-title":"Therapy of intracellular Staphylococcus aureus by tigecyclin","volume":"13","author":"Kreis","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bone.2022.116377_bb0830","first-page":"1647","article-title":"In vitro evaluation of a multifunctional nano drug delivery system based on tigecycline-loaded calcium-phosphate\/ poly-DL-lactide-co-glycolide","volume":"24","author":"Ignjatovi\u0107","year":"2014","journal-title":"Biomed. Mater. Eng."},{"key":"10.1016\/j.bone.2022.116377_bb0835","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1128\/AAC.04359-14","article-title":"Antimicrobial activity against intraosteoblastic Staphylococcus aureus","volume":"59","author":"Valour","year":"2015","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222000539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222000539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:15:32Z","timestamp":1778940932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328222000539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":167,"alternative-id":["S8756328222000539"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2022.116377","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetracyclines and bone: Unclear actions with potentially lasting effects","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2022.116377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116377"}}